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Adultneurogenicnichesharborquiescentneural stem
cells; however, their in vivo identity has been elusive.
Here, we prospectively isolate GFAP+CD133+ (quies-
cent neural stem cells [qNSCs]) and GFAP+CD133+
EGFR+ (activated neural stem cells [aNSCs]) from
the adult ventricular-subventricular zone. aNSCs are
rapidly cycling, highly neurogenic in vivo, and en-
riched in colony-forming cells in vitro. In contrast,
qNSCs are largely dormant in vivo, generate olfac-
tory bulb interneurons with slower kinetics, and only
rarely form colonies in vitro. Moreover, qNSCs are
Nestin negative, a marker widely used for neural
stemcells. Upon activation, qNSCs upregulateNestin
and EGFR and become highly proliferative. Notably,
qNSCs and aNSCs can interconvert in vitro. Tran-
scriptome analysis reveals that qNSCs share features
with quiescent stem cells from other organs. Finally,
small-molecule screening identified the GPCR li-
gands, S1P and PGD2, as factors that actively main-
tain the quiescent state of qNSCs.
INTRODUCTION
Quiescent and actively dividing (activated) stem cells coexist in
adult stem cell niches (Li and Clevers, 2010). Stem cell quies-
cence and activation play an essential role in many organs, un-
derlying tissue maintenance, regeneration, function, plasticity,
aging, and disease. Quiescent stem cells dynamically integrate
extrinsic and intrinsic signals to either actively maintain their
dormant state or become activated to divide and give rise to
differentiated progeny (Cheung and Rando, 2013). To illuminatetheir biology and their molecular regulation, it is essential to be
able to prospectively identify and purify quiescent stem cells.
However, this has been exceedingly difficult in any organ,
including the adult brain.
Adult neural stem cells (NSCs) continuously generate neurons
throughout life in two brain regions: the subgranular zone (SGZ)
of the hippocampus and the ventricular-subventricular zone
(V-SVZ), adjacent to the lateral ventricles. The V-SVZ is the
largest germinal region in the adult mammalian brain and gener-
ates olfactory bulb interneurons and oligodendrocytes. Within
the V-SVZ, glial fibrillary acidic protein (GFAP)-positive type
B cells with hallmark features of astrocytes are stem cells and
have multipotent self-renewing capacity in vitro (Doetsch et al.,
1999a; Laywell et al., 2000; Imura et al., 2003; Garcia
et al., 2004; Sanai et al., 2004; Ahn and Joyner, 2005; Mirzadeh
et al., 2008; Beckervordersandforth et al., 2010; Lee et al.,
2012). In vivo, actively dividing V-SVZ stem cells are eliminated
by antimitotic treatment (Pastrana et al., 2009). In contrast, slowly
dividing astrocytes are label-retaining cells (LRCs), survive treat-
ment with antimitotic drugs and regenerate the V-SVZ, and give
rise to neurons under homeostasis (Doetsch et al., 1999a; Ahn
and Joyner, 2005; Giachino and Taylor, 2009; Nam and Benezra,
2009; Kazanis et al., 2010; Basak et al., 2012).
Recently, novel features of the anatomical organization of the
V-SVZ stem cell niche have been uncovered. GFAP+ type B1
cells have a radial morphology and span different compartments
of the stem cell niche (Silva-Vargas et al., 2013). Their apical pro-
cesses contact the lateral ventricle at the center of pinwheel
structures formed by ependymal cells, exhibit a primary cilium,
and are exposed to signals in the cerebrospinal fluid (CSF)
(Doetsch et al., 1999a, Mirzadeh et al., 2008, Beckervordersand-
forth et al., 2010, Kokovay et al., 2012). Their basal processes
contact blood vessels, which are an important proliferative niche
in the adult V-SVZ (Shen et al., 2008; Mirzadeh et al., 2008; Ta-
vazoie et al., 2008; Kazanis et al., 2010; Kokovay et al., 2010, La-
car et al., 2011, 2012).Neuron 82, 545–559, May 7, 2014 ª2014 Elsevier Inc. 545
Figure 1. Two Populations of CD133+ V-SVZ
Astrocytes Contact the Ventricle
(A and B) A subset of GFAP+ cells at the center of
pinwheels express EGFR. (A) Confocal image of a
whole mount immunostained for b-catenin ([bCat]
red) to visualize pinwheels, GFAP (blue), and
EGFR (green). (B) Schematic representation of
whole mount shown in (A). Individual pinwheels
are highlighted in different colors, and EGFR-
expressing cells are green.
(C–F) Optical slice of a confocal z stack at the
ventricular surface of a whole mount showing
endogenous GFP expression (C) under the control
of the human GFAP promoter and immunostained
for (D) CD133 and (E) EGFR. (F) Merged image.
Note that astrocytes contacting the ventricle with
diffuse CD133 staining are EGFR+ (arrowheads),
whereas those with CD133 restricted to the pri-
mary cilium are EGFR (arrow).
(G) Schema showing type B1 astrocytes contact-
ing the ventricle at the center of a pinwheel
structure formed by ependymal cells (gray).
CD133 (Prominin, magenta) is detected on the cilia
of ependymal cells, some primary cilia of some
type B1 astrocytes (blue), and is diffusely ex-
pressed on the apical surface of EGFR+ type B1
astrocytes (cyan). Scale bars, 30 mm.
See also Figures S1 and S2.
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Purification of Adult Quiescent Neural Stem CellsVariousmolecular markers have been used for the in vivo iden-
tification of V-SVZ stem cells and their purification (reviewed in
Pastrana et al., 2011). Nestin and Sox2 are widely used as
NSC markers in both the embryonic and adult brain (Lendahl
et al., 1990; Graham et al., 2003; Kazanis et al., 2010; Imayoshi
et al., 2011; Marque´s-Torrejo´n et al., 2013). CD133 (Prominin),
a transmembrane glycoprotein expressed on primary cilia of
neural progenitors (Uchida et al., 2000; Marzesco et al., 2005;
Pinto et al., 2008; Cesetti et al., 2011) has been used to distin-
guish GFAP+CD133+ stem cells from niche astrocytes (Mirzadeh
et al., 2008, Beckervordersandforth et al., 2010). Combinations
of markers are beginning to be identified that allow the purifica-
tion of different subpopulations of V-SVZ cells, in particular of
activated stem cells, including epidermal growth factor receptor
(EGFR) (Doetsch et al., 2002; Pastrana et al., 2009), and brain
lipid binding protein (BLBP) (Giachino et al., 2014). To date, how-
ever, combinations of markers have not been identified that
allow the prospective isolation of quiescent V-SVZ stem cells.
This is crucial to illuminate the functional properties and gene
regulatory networks of quiescent adult NSCs.
Herein, we prospectively identify and isolate quiescent adult
NSCs from their niche. Our findings reveal that CD133+ astro-
cytes comprise two functionally distinct populations, quiescent
NSCs (qNSCs) and activated NSCs (aNSCs), which differ
dramatically in their in vivo cell cycle status and lineage kinetics,
their in vitro colony-forming efficiencies, and their molecular
signatures. Notably, qNSCs only rarely form colonies in vitro546 Neuron 82, 545–559, May 7, 2014 ª2014 Elsevier Inc.and are natively Nestin negative but
upregulate both Nestin and EGFR on
activation. qNSCs also share common
molecular features with their counter-parts in other organs. Finally, we identify GPCR ligands that
actively maintain the quiescent state of qNSCs.
RESULTS
Two Populations of CD133+ V-SVZ Astrocytes Contact
the Lateral Ventricle
The intermediate filament GFAP is one of the few markers of type
B1 astrocytes (Doetsch et al., 1997; Mirzadeh et al., 2008). How-
ever, due to its filamentous nature, it is difficult to perform colocal-
ization studieswithGFAP,and itcannotbeused for livecell sorting.
GFAP::GFP mice, in which GFP is expressed under the control
of the human GFAP promoter (Zhuo et al., 1997), are a useful
tool for visualizingV-SVZastrocytes invivoand for theirpurification
by fluorescence-activated cell sorting (FACS) (Tavazoie et al.,
2008; Platel et al., 2009, Shen et al., 2008, Pastrana et al., 2009;
Beckervordersandforth et al., 2010). Whole-mount preparations
allow the pinwheel architecture of the walls of the lateral ventricle
to be clearly visualized. We confirmed that, in GFAP::GFP mice,
type B1 astrocytes contacting the ventricle at the center of pin-
wheels were GFP+ and GFAP+, and frequently had a primary
cilium, but lacked S100b expression, a marker of mature astro-
cytes that are found deeper in the tissue at the interface with the
striatum (Figures S1A, S1C, and S1D available online).
Notably, a subset of cells localized within individual pinwheels
was EGFR+ (11.4% ± 1.3%; n = 129 pinwheels) (Figures 1A
and 1B). These ventricle-contacting EGFR+ cells coexpressed
Figure 2. Both Quiescent and Activated
CD133+ V-SVZ Astrocytes Have Radial
Morphology and Contact the Ventricle and
Blood Vessels
(A) Confocal images of whole mounts immuno-
stained with b-catenin ([b-cat] green, superficial
optical slice) showing cells labeled by in vivo
electroporation of the mP2-mCherry construct
(red, z stack projection). Labeled cells are either
radial cells that contact the ventricle at the center
of pinwheels (open arrowheads in insets) or
ependymal cells (asterisks).
(BI–CIII) Confocal images of whole mounts immu-
nostained with Laminin (cyan), b-catenin (green),
and MCM2 (blue) showing projections of mP2-
mCherry+ cells (BI and CI). Insets show superficial
(BII and CII) and deep (BIII and CIII) optical slices.
Both MCM2 and MCM2+ cells contact the
ventricle at the center of pinwheels as well as
blood vessels.
(DI–EIII) Confocal images of whole mounts immu-
nostained with MCM2 (cyan) and b-catenin (blue)
and labeled with EGF-A647 (green) showing pro-
jections of mP2-mCherry+ cells (DI and EI). Insets
show superficial (DII and EII) and deep (DIII and EIII)
optical slices. Note that EGF-negative cells are
MCM2. Scale bars, 30 mm.
See also Figure S3.
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Purification of Adult Quiescent Neural Stem Cellsboth GFAP protein and GFP in GFAP::GFP mice (Figure S1B;
Pastrana et al., 2009) and were observed throughout the rostro-
caudal axis of the V-SVZ, with 45.7% ± 4.4% of pinwheels con-
taining EGFR+ cells.
To define markers for EGFR-negative type B1 cells contacting
the ventricle, we examined the expression of CD133 (Prominin),
which is expressed by ependymal cells and on the primary cilium
of some type B1 cells (Coskun et al., 2008; Mirzadeh et al., 2008;
Beckervordersandforth et al., 2010). We immunostained whole
mounts of GFAP::GFP mice for EGFR and CD133 in conjunction
with b-catenin (to label pinwheels) or acetylated tubulin (to detect
primary cilia). We thereby identified two CD133+ astrocyte pop-
ulations: GFAP::GFP+CD133+ and GFAP::GFP+CD133+EGFR+
(Figure 1G). GFAP::GFP+CD133+ cells had a primary cilium
with CD133 staining localized to its tip (Figures 1C–1F; Figures
S2A and S2C). In contrast, GFAP::GFP+CD133+EGFR+ cells ex-
hibited diffuse CD133 staining over their apical surface and
lacked a primary cilium (Figures 1C–1F; Figures S2B and S2D).
Finally, we also observed GFAP::GFP+ cells contacting the
ventricle, which had a primary cilium that was CD133 negative
(Figures S2A and S2C).
Visualizing the in vivo morphology of CD133+ type B1 cells is
not feasible by immunostaining. To this end, we cloned and elec-
troporated a construct that expresses membrane-targeted
mCherry under the control of the mouse minimal P2 (Prominin-1)Neuron 82, 545promoter (mP2-mCherry; Figure S3A)
into the lateral ventricle and analyzed
whole mounts 2 days later. Both multicili-
ated flat ependymal cells possessing
typical cuboidal morphology and radialcells with B1 morphology were labeled by this construct (Fig-
ure 2A), and all coexpressed CD133 protein (23/23 cells; Figures
S3B–S3D). Radial mP2-mCherry+ cells expressed CD133 either
at the tip of their primary cilium (Figure S3C) or diffusely on their
apical surface (Figure S3D) and were GFAP+ (data not shown).
To define the cell cycle status and relationship of radial mP2-
mCherry+ cells with ependymal cells and blood vessels, electro-
porated whole mounts were immunostained for combinations of
EGF-A647, MCM2, b-catenin, and Laminin to label activated
stem cells, dividing cells, pinwheels, and blood vessels, respec-
tively. All radial mP2-mCherry+ cells, regardless of MCM2
expression or epidermal growth factor (EGF)-ligand binding,
had a typical B1 morphology with an apical process contacting
the ventricle at the center of pinwheels and a long basal process
extending away from the surface, which frequently terminated on
blood vessels (Figures 2BI–2BIII; Figures 2CI–2CIII; Figures S3E–
S3N). Importantly, all MCM2+ radial mP2-mCherry+ astrocytes
were colabeled with EGF-ligand (70/70 cells MCM2 and
EGF; 5/5 cells MCM2+ and EGF+; Figures 2DI–2DIII; Figures
2EI–2EIII).
Prospective Purification of V-SVZ Astrocytes
The aforementioned in vivo characterization suggests that
CD133 and EGFR could be used as markers to prospectively
purify quiescent and activated NSCs directly from their in vivo–559, May 7, 2014 ª2014 Elsevier Inc. 547
Figure 3. Prospectively Purified CD133+
Astrocyte Subpopulations Exhibit Different
Cell Cycle Properties
(A and B) Representative FACS plots showing
gating strategy. In (A), the gate used to select
GFAP::GFP+CD24- cells, which are then gated on
EGF-A647 and CD133-PE-Cy7. In (B), three pop-
ulations are clearly defined: GFAP::GFP+ (gray),
GFAP::GFP+CD133+ (blue), and GFAP::GFP+
CD133+EGFR+ (cyan).
(C) Histogram showing the intensity of GFP
signal in GFAP::GFP+, GFAP::GFP+CD133+, and
GFAP::GFP+CD133+EGFR+ populations (gray,
blue, and cyan, respectively) compared to other
V-SVZ cells (GFP, black). Note that GFAP::
GFP+CD133+EGFR+ cells are dimmer than
GFAP::GFP+ and GFAP::GFP+CD133+ cells.
(D) Proportion of each CD133+-purified astrocyte
subpopulation that expresses Ki67 and MCM2
(n = 3; **p < 0.01, unpaired Student’s t test;
mean ± SEM).
(E) Proportion of each CD133+-purified astrocyte
subpopulation labeled after a single pulse of BrdU
(light green) or after 14 days of BrdU in the drinking
water (dark green) (n = 3 and n = 4, respectively,
**p < 0.01, unpaired Student’s t test, mean ± SEM).
(F) LRC fraction in the CD133+-purified astrocyte
populations 14 or 30 days after 14 days of BrdU
administration (n = 4, mean ± SEM).
(G) Representative FACS plots of CD133+ astro-
cyte subpopulations from saline- and Ara-C-
treated mice.
(H) Summary of markers expressed by CD133+-
purified astrocytes.
See also Figures S4 and S6.
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to simultaneously isolate activated stem cells (GFAP::GFP+
EGFR+), transit-amplifying cells (EGFR+), and neuroblasts
(CD24+) by combining EGF-A647 and CD24 in GFAP::GFP
mice (Pastrana et al., 2009). By including CD133 in this sorting
strategy, we separated two CD133+ astrocyte populations,
GFAP::GFP+CD133+ and GFAP::GFP+CD133+EGFR+, from the
remaining GFAP::GFP+-only cells (Figures 3A and 3B; Figures
S4A–S4I). GFAP::GFP+CD133+ (ranging from 25% to 30% of
total GFP+ cells) and GFAP::GFP+CD133+EGFR+ (20%–25% of
total GFP+ cells) were both abundant but differed in their GFP
brightness (Figure 3C).
We assessed the purity of the sorted populations using qRT-
PCR and acute immunostaining. qRT-PCR confirmed that sorted
populations were appropriately enriched in Gfap, GFP, Prom1,
and Egfr expression (Figures S4Q–S4T). Acute immunostaining
showed that both GFAP::GFP+CD133+ and GFAP::GFP+
CD133+EGFR+ populations were highly enriched in GLAST and
GLT1 (Figures S4J and S4K)—glutamate aspartate transporters
expressed in astrocytes—as well as BLBP (Figure S4M), that
they largely or completely lacked S100b (Figure S4L) and that
they were almost completely negative for the neuroblast markers
DCX and bIII tubulin (Figures S4O and S4P). Notably, more than
90% of GFAP::GFP+CD133+ and GFAP::GFP+CD133+EGFR+
populations expressed the NSC transcription factor Sox2
(Figures S4N and S4U). High Sox2 levels are related to a more548 Neuron 82, 545–559, May 7, 2014 ª2014 Elsevier Inc.proliferative state (Marque´s-Torrejo´n et al., 2013); of note,
92.8% ± 1.5% of GFAP::GFP+CD133+EGFR+ cells expressed
high levels of Sox2 protein, whereas only 38.4% ± 3.5% of
GFAP::GFP+CD133+ cells were Sox2 bright, with the remainder
being Sox2 dim. In contrast, the GFAP::GFP+-only population
was more heterogeneous with significant neuroblast contamina-
tion, likely due to perdurance of GFP in neuroblasts (Figures S4O
and S4P). We therefore focused our functional analyses below
on GFAP::GFP+CD133+ and GFAP::GFP+CD133+EGFR+ popu-
lations (all data regarding the GFAP::GFP+-only population are
included in Figure S6).
Purified GFAP+CD133+ V-SVZ Cells Have Different Cell
Cycle Properties
Quiescent stem cells are largely dormant and lack markers of
proliferation such as Ki67 and MCM2 that are expressed in
actively dividing cells, but not during the quiescent G0 state
(Maslov et al., 2004). Both markers are expressed during G1,
with MCM2 being expressed earlier than Ki67. Cycling GFAP+
V-SVZ cells in vivo have a fast cell cycle (Ponti et al., 2013). To
determine the cell cycle properties of CD133+ astrocyte sub-
populations in vivo, we used multiple approaches. First, we
determined the instantaneous cell cycle status of FACS-purified
cells by acute immunostaining for proliferation-associated
markers. GFAP::GFP+CD133+EGFR+ cells were highly enriched
in both Ki67 and MCM2 (64% ± 5.2% and 87.3% ± 1.2%,
Neuron
Purification of Adult Quiescent Neural Stem Cellsrespectively) whereas these two markers were almost absent in
GFAP::GFP+CD133+ cells (1.4% ± 0.9% and 0.0% ± 0.0%,
respectively) (Figure 3D). Similar patterns of proliferation were
observed after a single in vivo pulse of bromodeoxyuridine
(BrdU) 1 hr prior to FACS isolation: 35.5% ± 1.8% of
GFAP::GFP+CD133+EGFR+ cells were BrdU+, in contrast to
0.8% ± 0.8% of GFAP::GFP+CD133+ cells (Figure 3E). Thus, at
any given moment, the vast majority of GFAP::GFP+CD133+
cells are not proliferating.
LRCs are slowly cycling cells whose DNA remains labeled
after prolonged administration of thymidine analogs and a long
chase period (Wilson et al., 2008). To label dividing cells and to
identify LRCs, we administered BrdU via drinking water for
2 weeks and analyzed the proportion of each population that
was BrdU+. Immediately after BrdU treatment, almost all
GFAP::GFP+CD133+EGFR+ cells were labeled, whereas only
3.9% ± 0.4% of GFAP::GFP+CD133+ cells had incorporated
BrdU, reflecting their much slower rate of division (Figure 3E).
Fourteen days after ceasing BrdU treatment, GFAP::GFP+
CD133+EGFR+ cells had already almost completely lost BrdU
labeling (Figure 3F). In contrast, 52.4% ± 17.3% of GFAP::GFP+
CD133+ cells were still BrdU+ 30 days after BrdU withdrawal
(Figure 3F).
Finally, we confirmed the different proliferation characteristics
of both populations in vivo by infusing cytosine-b-D-arabinofur-
anoside (Ara-C) directly on the brain surface to eliminate dividing
cells (Doetsch et al., 1999b). GFAP::GFP+CD133+ cells survived
6 days of Ara-C treatment, whereas the more rapidly dividing
GFAP::GFP+CD133+EGFR+ cells were eliminated (Figure 3G).
Thus, although CD133 is regulated in a cell-cycle-dependent
manner in dividing neural cell lines (Sun et al., 2009), in the
V-SVZ niche, CD133 is expressed in both dividing and nondi-
viding cells in vivo.
Together, these findings reveal that GFAP::GFP+CD133+ cells
are largely quiescent in vivo, whereas GFAP::GFP+CD133+
EGFR+ cells are actively dividing. Based on their cell cycle prop-
erties and the functional studies described below, hereafter we
refer to these populations as qNSCs and aNSCs, respectively
(Figure 3H).
qNSCs and aNSCsAreBothNeurogenic In Vivo butDiffer
in Their Kinetics
To assess the in vivo potential of quiescent and activated stem
cells, we transplanted purified qNSCs (1 week, n = 8; 1 month,
n = 5) and aNSCs (1 week, n = 5; 1 month, n = 11) isolated
fromGFAP::GFP;b-Actin-PLAPmice (Zhuo et al., 1997; DePrimo
et al., 1996) into the SVZ of wild-type recipient mice (Figure 4A).
The donor cells were histochemically visualized based on their
expression of the reporter human placental alkaline phospha-
tase (PLAP). In mice transplanted with aNSCs, many migrating
neuroblasts were present in the V-SVZ, the rostral migratory
stream (RMS), and the olfactory bulb after only 1 week (Figures
4E–4G), confirming their activated state. However, in mice trans-
planted with qNSCs, no neuroblasts were observed at this time
point, and PLAP+ cells were only present in the V-SVZ (Figures
4B–4D). In contrast, after 1 month, both populations generated
mature olfactory bulb interneurons (Figures 4J and 4M), and
PLAP+ cells were still present in the V-SVZ in all transplants (Fig-ures 4H and 4K). Interestingly, migrating neuroblasts were also
present in the RMS in 3 out of 5 qNSC and 3 out of 11 aNSC
transplanted brains, demonstrating that both populations
continue to generate neurons after 1 month in vivo (Figures 4I
and 4L). Oligodendrocytes were also formed by both trans-
planted populations (data not shown). These data show that
both qNSCs and aNSCs can give rise to neurons and retain
long-term neurogenic potential in vivo but exhibit very different
kinetics of cell generation.
qNSCs and aNSCs Differ in Their In Vitro Behavior and
Can Interconvert States
Two in vitro assays are widely used to assess stem cell proper-
ties and to enumerate in vivo stem cells: adherent colony forma-
tion and neurospheres (Pastrana et al., 2011). With the ability to
now prospectively purify qNSCs, we directly tested their in vitro
behavior in both assays, as compared to aNSCs.
qNSCs and aNSCs were plated as single cells under adherent
conditions in the presence of EGF or EGF/basic fibroblast
growth factor (bFGF). Whereas aNSCs were enriched in colony
formation (47.9% ± 11.9% in EGF and 41.4% ± 1.8% in EGF/
bFGF), in striking contrast, qNSCs only rarely gave rise to
colonies (1.2% ± 0.1% in EGF and 0.7% ± 0.2% in EGF/bFGF)
(Figure 5A) and did so with much slower growth kinetics than
aNSCs. Importantly, although rare, the colonies formed by single
qNSCs were large and multipotent, giving rise to neurons, oligo-
dendrocytes, and mature astrocytes (Figures 5B and 5C).
We next compared the ability of qNSCs and aNSCs to form
neurospheres and assessed self-renewal by serial passaging.
Again, qNSCs only rarely gave rise to neurospheres (0.85% in
EGF, 0.82% in EGF/bFGF) in contrast to aNSCs, which robustly
generated neurospheres (Figure S5B). Moreover, the prolifera-
tion of the qNSC population was delayed by 6 days compared
to aNSCs (Figures 5D and S5A). However, once activated,
qNSCs exhibited similar rates of division to aNSCs. Neuro-
spheres from both populations could be serially passaged
more than three times and were multipotent, giving rise to
neurons, astrocytes, and oligodendrocytes (Figures S5B and
S5E). Finally, we examined whether more qNSCs were recruited
to form neurospheres during in vivo regeneration, at 12 hr post-
Ara-C removal when stem cell astrocytes start to divide (Doetsch
et al., 1999a, 1999b; Pastrana et al., 2009). Notably, the effi-
ciency of neurosphere formation of qNSCs purified after Ara-C
treatment did not increase (Figure 5K). However, as previously
shown, total neurosphere formationwas almost completely elim-
inated after Ara-C treatment (Doetsch et al., 2002; Imura et al.,
2003;Morshead et al., 2003; Garcia et al., 2004; data not shown),
confirming that the vast majority of neurospheres arise from
actively dividing cells.
Together, these results reveal that aNSCs are highly enriched
in colony formation. In contrast, the qNSC population rarely
forms colonies and does so more slowly than aNSCs. However,
once activated, qNSCs are highly proliferative and multipotent,
almost indistinguishable from aNSCs (Figure S5B). We therefore
assessedwhether qNSCs and aNSCs can interconvert in vitro by
dissociating and analyzing primary spheres by flow cytometry.
Intriguingly, the vast majority of cells in neurospheres derived
from qNSCs expressed both EGFR and CD133 (Figures 5ENeuron 82, 545–559, May 7, 2014 ª2014 Elsevier Inc. 549
Figure 4. qNSCs and aNSCs Are Neuro-
genic In Vivo
(A) Schema of experimental design.
(B–G) Horizontal brain sections showing PLAP+
cells (purple, arrowheads) 1 week after trans-
plantation of qNSCs (B–D) and aNSCs (E–G). At
this time point, aNSCs generated numerous
migrating neuroblasts, whereas no cells were de-
tected in the RMS or in the olfactory bulb of brains
transplanted with qNSCs.
(H–M) Horizontal brain sections showing PLAP+
cells (purple, arrowheads) 1 month after trans-
plantation of (H–J) qNSCs and (K–M) aNSCs. In
transplants from both populations, cells were
present in the V-SVZ and RMS and had generated
mature olfactory bulb interneurons. Scale bars,
200 mm. STR, striatum; CP, choroid plexus; LV,
lateral ventricle; GCL, granular cell layer; PGL,
periglomerular layer.
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Purification of Adult Quiescent Neural Stem Cellsand 5G), revealing that qNSCs give rise to GFAP::GFP+CD133+
EGFR+ cells in vitro. Conversely, aNSCs gave rise to both
GFAP::GFP+CD133+ and GFAP::GFP+ populations (Figures 5F
and 5H). Moreover, when primary spheres were dissociated
and GFAP::GFP+CD133+, GFAP::GFP+CD133+EGFR+, and
GFAP::GFP+ cells were reisolated, each population exhibited
similar sphere formation efficiencies to primary isolated cells,
with the GFAP::GFP+CD133+EGFR+ population being greatly
enriched in neurosphere formation compared to GFAP::GFP+
CD133+ andGFAP::GFP+ populations (Figures 5I and 5J; Figures
S5C and S5D). Therefore, qNSCs and aNSCs can interconvert
between more quiescent and activated states, with each popu-
lation giving rise to all other populations in vitro.550 Neuron 82, 545–559, May 7, 2014 ª2014 Elsevier Inc.qNSCs Do Not Express Nestin but
Upregulate EGFR and Nestin on
Activation
Nestin is an intermediate filament protein;
its expression is widely considered a
hallmark of NSCs, both during develop-
ment and in the adult (Lendahl et al.,
1990; Imayoshi et al., 2011). Unexpect-
edly, our microarray analysis (see below)
suggested that qNSCs express very low
to no levels of Nestin mRNA, in contrast
to aNSCs, in which Nestin mRNA is highly
expressed. We confirmed this observa-
tion by qRT-PCR (Figure S8E) as well as
by immunostaining of acutely purified
cells (Figure 6A). Out of 1,582 plated
qNSCs, none were Nestin protein posi-
tive. Finally, to assess the Nestin status
of NSCs in vivo, we electroporated mice
with the mP2-mCherry construct and
coimmunostained whole mounts with
Nestin and EGF-ligand. In vivo, Nestin is
highly expressed by ependymal cells
(Doetsch et al., 1997; Figures 6DI and
6EI) as well as SVZ cells (Figures 6DIIand 6EII). All radial EGF-ligand-negative mP2-mCherry+ cells
were Nestin protein negative (Figures 6DI and 6DII; 0/79 cells
in seven whole mounts). In contrast, only EGF-ligand-positive
cells coexpressed Nestin protein (Figures 6EI and 6EII; 32/34
cells in seven whole mounts).
To investigate whether qNSCs upregulate Nestin protein on
activation, we performed a time-course analysis of qNSCs
cultured in adherent conditions and immunostained for Nestin,
EGFR, and MCM2 (Figures 6B and 6C). When first isolated and
plated, qNSCswere small and round and did not express Nestin,
EGFR, or MCM2 (type 1). As qNSCs became activated in vitro,
they underwent morphological and molecular changes,
enlarging their nuclei and upregulating all three markers
Figure 5. Purified qNSCs and aNSCs Give Rise to Neurospheres with Different Proliferative Properties and Kinetics
(A) Single cell colony formation efficiency of FACS-purified qNSCs and aNSCs in adherent cultures (n = 3, mean ± SEM).
(B) Representative phase contrast image of an adherent colony from a single qNSC after 12 days in the presence of EGF. Scale bar, 100 mm.
(C) Confocal image of neurons (bIII Tubulin [b III Tub], red), astrocytes (GFAP, green) and oligodendrocytes (O4, blue) derived from qNSCs plated under adherent
conditions. Scale bar, 10 mm.
(D) Quantification of cell proliferation when plated at 1.4 cells per microliter with EGF under nonadherent conditions after 6 or 12 days (n = 5; **p < 0.01 compared
to qNSCs at the same time point, unpaired Student’s t test, mean ± SEM).
(E–H) Representative FACS plots of, in (E) and (F), purified CD133+ astrocytes immediately resorted after isolation from the brain and, in (G) and (H), of primary
neurospheres (NS) derived from each population after 12 days for qNSCs and 6 days for aNSCs cultured in EGF.
(I and J) Clonal activation efficiency of purified GFAP::GFP+, GFAP::GFP+CD133+, and GFAP::GFP+CD133+EGFR+ cells, isolated from primary neurospheres of
each population (in EGF, n = 3; *p < 0.05, **p < 0.01, unpaired Student’s t test; mean ± SEM).
(K) Neurosphere formation 12 hr (12h) after Ara-C treatment as compared to saline-treated controls (n = 6, mean ± SEM).
See also Figures S5 and S6.
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6C) and began to proliferate extensively, closely resembling
cultured aNSCs.
To independently confirm the lack of Nestin expression in
qNSCs and its upregulation on activation, we usedNestin::Kusa-
bira Orange reporter mice (Kanki et al., 2010; Ishizuka et al.,
2011) to FACS-purify CD133+Nes::OREGFRCD24 (Nestin-
and EGFR-negative) cells (Figure S7A). Acutely plated cells all
lacked Nestin protein (Figure S7B) and, when cultured, only
rarely gave rise to neurospheres (Figures S7C and S7E). Impor-
tantly, CD133+Nes::OR-EGFRCD24 cells, which originally
lacked Nestin::Kusabira Orange reporter expression, upregu-
lated the reporter in all neurospheres that formed (Figure S7C).
In contrast, purified CD133+Nes::OR+EGFR+CD24 cells were
very efficient in neurosphere formation (Figures S7D and S7E).Finally, we examined whether Nestin-negative qNSCs
contribute to the lineage during regeneration. At present, it is
not feasible to directly trace the lineage of qNSCs in vivo
due to the lack of specific markers. We therefore adminis-
tered tamoxifen to adult GFAP::CreERT2;Rosa26tdTomato mice
to induce recombination in GFAP-expressing cells and chased
for 10 days after the first injection to allow actively dividing
cells to progress down the lineage (Figure S7F). We then
infused Ara-C for 6 days to eliminate dividing cells (Fig-
ure S7F) and confirmed that all remaining lineage-labeled
cells were Nestin negative (0 of 951; Figure S7G) immediately
after termination of treatment. Six days after Ara-C removal,
tdTomato+Nestin+ cells were present (Figures S7H and S7I), as
well as tdTomato+DCX+ neuroblasts (Figure S7I). These data
reveal that qNSCs upregulate Nestin, as well as EGFR, duringNeuron 82, 545–559, May 7, 2014 ª2014 Elsevier Inc. 551
Figure 6. qNSCs Are Nestin Negative
(A) Proportion of acutely plated purified qNSCs and aNSCs immunopositive for MCM2 and Nestin (n = 3, mean ± SEM).
(B) Images of FACS-purified qNSCs cultured in EGF, fixed at different time points, and immunostained with EGFR, MCM2, and Nestin. Three types of cells are
present: rounded cells with a condensed nucleus that do not express EGFR, MCM2, or Nestin (type 1); rounded cells with a larger nucleus that express EGFR,
MCM2, and Nestin (type 2); and EGFR+MCM2+Nestin+ cells with elongated processes (type 3). Type 3 cells resemble aNSCs after 3 days in culture. Scale bars,
10 mm.
(C) Quantification of activated qNSCs in culture after 2 hr or after 1, 3, 5, or 7 days after plating (n = 4, mean ± SEM).
(DI–EII) Confocal images showing mP2-mCherry+ cells (red) in whole mount labeled with EGF-A647 (green) and immunostained for Nestin (blue). In (D), two cells
contact the ventricle between ependymal cells, do not bind EGF-A647 (DI, arrows), and are Nestin negative in the subventricular projection (DII). In (E), an EGF-
A647-labeled cell (EI, arrow) is coimmunostained with Nestin in the subventricular projection (EII, arrowheads in inset). Notably, not all processes contained
Nestin. Scale bars, 30 mm.
See also Figure S7.
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in vivo.
Gene Expression Analysis of Purified qNSCs and aNSCs
Reveals Distinct Molecular Signatures
To gain insight into the biological properties of qNSCs and to
define their molecular signatures, we performedmicroarray anal-
ysis on RNA from FACS-purified populations isolated directly
from their in vivo niche (Figure 7A; Table S1). Gene ontology
(GO) and gene set enrichment analysis (GSEA) (Subramanian
et al., 2005) revealed that qNSCs and aNSCs have distinct
molecular features (Figures 7B–7D). Confirming the actively552 Neuron 82, 545–559, May 7, 2014 ª2014 Elsevier Inc.dividing state of aNSCs in vivo, their transcriptome was enriched
in genes involved in the cell cycle, transcription and translation,
and DNA repair (Figures 7C and 7D; Tables S2 and S3). In
contrast, qNSCs were enriched in the GO categories of cell
communication, response to stimulus, and cell adhesion (Fig-
ure 7B; Table S2), underscoring the dynamic regulation of the
quiescent state via interaction with the microenvironment.
Indeed, the most represented GSEA groups for qNSCs were
related to transport, signaling, receptors, cell surface, and extra-
cellular matrix (Figure 7D; Table S3). Notably, qNSCs and aNSCs
exhibited different metabolic profiles; themajority of the differen-
tially enriched GSEAmetabolism subsets in qNSCs were related
Figure 7. Gene Expression Analysis of qNSCs and aNSCs Reveals Distinct Molecular Signatures
(A) Volcano plot of differentially expressed probesets in qNSCs and aNSCs. Probes have at least 2-fold change in expression and a corrected p value < 0.05.
(B and C) Pie charts showing representative GO categories for differentially expressed probesets in (B) qNSCs and (C) aNSCs, as determined in (A).
(D) GSEA for qNSCs versus aNSCs. Sets have a false discovery rate (q value) <0.05 and are hand curated into thematic categories.
(E and F) Percentage of overlap with signatures of quiescent and dividing stem cells from other organs: (E) long-term (LT)/quiescent signatures and (F) short-term
(ST)/proliferative signatures as determined by fold-change analysis of published lists compared to qNSC and aNSC populations. Qui, quiescent; HSC,
hematopoietic stem cells; qMuSC, quiescent muscle stem cells; qBulgeSC, quiescent bulge stem cells; qISC, quiescent intestinal stem cells.
(G–J) Targeted GPCR ligand screen. (G) Quantification of qNSC activation (fold change in % Nestin+ clones) as compared to controls (empty dots). (H) Quan-
tification of percentage of MCM2+ cells within activated Nestin+ clones. (I) Quantification of aNSC clones (fold change of percentage of clones that underwent
division) as compared to controls (empty dots). (J) Quantification of percentage of MCM2+ aNSCs. Data are represented as means ± SEM.
n = 3. *p < 0.05; ***p < 0.001. ns, not significant.
See also Figure S8 and Tables S1, S2, S3, S4, S5, S6, S7, and S8.
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important signals in NSC regulation (Knobloch et al., 2013),
whereas those in aNSCs were DNA/RNA-related metabolism
and proteasome activity (Figure S8B).
Functional studies have implicated numerous genes in the
regulation of adult neurogenesis. Many of these were differen-tially expressed in qNSCs and aNSCs (Table S5). Moreover,
direct comparison of qNSC and aNSC transcription profiles
with those of purified GFAP::GFP+CD133+ V-SVZ stem cells
(Beckervordersandforth et al., 2010) revealed that we have
resolved two distinct subsets of NSCs with different molecular
and functional properties within their data (Figures S8C andNeuron 82, 545–559, May 7, 2014 ª2014 Elsevier Inc. 553
Figure 8. In Vivo and In Vitro Properties of
V-SVZ Stem Cells and Their Progeny
Quiescent stem cells (GFAP+CD133+) are Nestin
negative, label-retaining (blue line), and neuro-
genic in vivo (magenta line) but only very rarely give
rise to neurospheres and adherent colonies in vitro
(light blue line). Activated stem cells (GFAP+
CD133+EGFR+) are highly proliferative (green line)
and rapidly generate neurons in vivo and are en-
riched in neurosphere/colony formation. Previous
work has shown that EGFR+ transit amplifying cells
are also highly proliferative in vivo and give rise to
neurospheres. Of note, quiescent stem cells were
also present among CD133- astrocytes. Niche
astrocytes have a branched morphology.
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factors such as Dlx1, Dlx2, Sox4, Sox11, and Ascl1, which
were proposed to be hallmarks of NSCs (Beckervordersandforth
et al., 2010), were in fact primarily expressed by or restricted to
aNSCs (Table S4). We confirmed enrichment ofDlx2 andAscl1 in
aNSCs by qRT-PCR (Figures S8F and S8G), as well as enrich-
ment of Dll1 (Figure S8H), which is expressed in aNSCs (Kawa-
guchi et al., 2013). In contrast, qNSCs expressed high levels of
factors reported to be markers of quiescent stem cells in the
adult V-SVZ, such as Vcam1 (Figure S8I and Table S5; Kokovay
et al., 2012), and in other organs, such as Lrig1 (Figure S8J and
Table S1; Jensen and Watt, 2006; Jensen et al., 2009; Powell
et al., 2012).
We then performed comparative analysis of our gene expres-
sion data with transcriptional signatures from quiescent or prolif-
erative hematopoietic, muscle, skin, and intestinal stem cells
(Ivanova et al., 2002; Venezia et al., 2004; Forsberg et al.,
2010; Pallafacchina et al., 2010; Powell et al., 2012; Blanpain
et al., 2004: Fukada et al., 2007; Cheung and Rando, 2013).
The majority of genes in long-term/quiescent populations were
upregulated in our quiescent V-SVZ stem cells, whereas those
in the short-term/proliferative stem cell lists from other tissues
were upregulated in our activated population (Figures 7E and
7F; Table S6). Together, this suggests that common transcrip-
tional programs for quiescence or activation are shared between
stem cell lineages in different tissues.
GPCR Signaling Maintains the Quiescent State
To gain insight into signaling pathways that modulate quies-
cence in qNSCs, we mined our transcriptome data. G protein-
coupled receptor (GPCR) signaling was highly enriched in
qNSCs (30% of all GSEA signaling sets; Table S3). We selected
25 GPCRs that were more than 10-fold enriched in qNSCs over
aNSCs (Table S7) as a basis for a functional screen to assess554 Neuron 82, 545–559, May 7, 2014 ª2014 Elsevier Inc.their role in the regulation of qNSCs.
FACS-purified qNSCs were plated under
adherent conditions for 4 days in the
presence of different ligands, and their
activation (number of Nestin+ clones)
was quantified (Figure S8K). Two com-
pounds, sphingosine-1-phosphate (S1P)and prostaglandin D2 (PGD2), had a significant effect, with both
decreasing the activation of qNSCs by approximately one half
(Figures 7G and S8L). Both ligands also decreased the number
of MCM2+ qNSCs (Figure 7H). PGD2 exerted a more potent
effect, completely abolishing MCM2 expression. To determine
whether these compounds act specifically on qNSCs or also
affect aNSCs, we plated FACS-purified aNSCs in the presence
of S1P or PGD2 and fixed the cells after 24 hr. This shorter
time course is necessary as aNSCs divide very rapidly, making
it difficult to distinguish individual clones (Figure S8K). S1P did
not alter the number of aNSC clones (Figure 7I) or percentage
of MCM2+ cells (Figure 7J). As such, S1P selectively targets
qNSCs and appears to act at the level of qNSC recruitment
(Figure 7H). In contrast, PGD2 had a potent inhibitory effect
on the number of clones formed by aNSCs (Figure 7I). PGD2
also reduced the percentage of MCM2+ aNSCs (Figure 7J).
As such, PGD2 acts on both qNSCs and aNSCs. Thus,
these GPCR ligands actively maintain the adult NSC quiescent
state.
DISCUSSION
Here, we prospectively identified and isolated quiescent
adult NSCs by defining a combination of markers (CD133,
GFAP, and EGFR) that allows the simultaneous purification of
quiescent and activated populations of stem cell astrocytes.
Together, our analyses of their cell cycle properties, their
morphological and anatomical localization, their in vitro and
in vivo functional behavior, and their gene expression profiles
highlight the distinct functional and molecular properties of
qNSCs and aNSCs (Figure 8). Our functional analyses reveal
important features of quiescent NSCs, which affect the interpre-
tation of commonly used in vitro NSC assays and lineage-tracing
strategies.
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exclusively expressed by ependymal cells, with FACS-purified
CD133+ cells giving rise to neurospheres in vitro and generating
neurons in vivo (Coskun et al., 2008). However, CD133 is also
expressed by a subset of astrocytes, which behave as NSCs
(Mirzadeh et al., 2008; Beckervordersandforth et al., 2010), sug-
gesting that the earlier findings can be attributed to CD133+
astrocytes instead of ependymal cells. Here, we show that
CD133 is expressed by both quiescent and activated V-SVZ
stem cells.
The neurosphere assay is widely used as a readout of in vivo
stem cells (reviewed in Pastrana et al., 2011). Neurospheres
were originally proposed to arise from relatively quiescent stem
cells in vivo (Morshead et al., 1994). With the ability to prospec-
tively purify cells at different stages of the stem cell lineage, it is
now feasible to directly assess the potential of distinct popula-
tions to give rise to neurospheres. Here, we show that qNSCs
only very rarely give rise to either neurospheres or adherent
colonies and do not increase their neurosphere-forming effi-
ciency during regeneration. In contrast, aNSCs are enriched in
neurosphere and adherent colony formation. Together, our
current findings and previous reports highlight that the major
source of neurosphere-initiating cells are actively dividing in vivo,
and include both GFAP+ aNSCs and EGFR+GFAP- transit-ampli-
fying cells (Doetsch et al., 2002, Imura et al., 2003; Morshead
et al., 2003; Garcia et al., 2004, Pastrana et al., 2009; data not
shown). Thus, the neurosphere assay is a useful tool for assess-
ing the in vitro stem cell potential of proliferative populations but
does not allow the identification and enumeration of in vivo
quiescent stem cells. This emphasizes the need to develop novel
assays, or identify additional niche factors, that allow qNSCs to
be expanded in vitro.
Nestin is frequently usedboth as amarker of NSCs and for their
geneticmanipulation and lineage tracing in the embryonic (Lend-
ahl et al., 1990; Zimmerman et al., 1994) and adult brain (reviewed
in Imayoshi et al., 2011). Nestin+ cells have also been implicated
as putative glioblastoma-forming cells (Holland et al., 2000, Chen
et al., 2012). Notably, we found that adult V-SVZ qNSCs do not
express Nestin but upregulate it on activation in vitro, as well
as during regeneration in vivo. These data are consistent with
previous observations that Nestin/CD133+ cells are neurogenic
in vivo and give rise to Nestin+ neurospheres in vitro (Coskun
et al., 2008). Recently, both Nestin-negative and Nestin-positive
radial glia-like stem cells have also been described in the hippo-
campus (DeCarolis et al., 2013). Aswe show here in the V-SVZ, in
the SGZ, almost all of the dividing radial glia-like stem cells
express Nestin (DeCarolis et al., 2013). It is interesting that, in
embryonic development, Nestin expression is also regulated in
a cell-cycle-dependent manner (Sunabori et al., 2008). Thus,
Nestin expression is dynamically regulated in NSCs. Importantly,
our study highlights that Nestin immunostaining cannot be used
to identify adult qNSCs in vivo. Thus, whether recombination and
reporter expression occur in qNSCs needs to be carefully
assessed when using Nestin transgenes for in vivo targeting of
adult NSCs, V-SVZ lineage tracing, genetic manipulation, or
purification. Moreover, interpretation of such assays is further
complicated by the high expression of Nestin in ependymal cells,
which can lead to nonautonomous effects.qNSCs are multipotent and self-renewing in vitro. In vivo,
qNSCs are long-term neurogenic and exhibit delayed kinetics
of neuron formation compared to aNSCs. Interestingly, some
aNSC transplants also continue to make neurons 30 days after
transplantation. These may arise from a more quiescent sub-
population of aNSCs or from aNSCs that have reverted back
to the quiescent state, as occurs in vitro. We also observed
oligodendrocyte formation by both transplanted qNSCs and
aNSCs (data not shown). In vivo, adult V-SVZ NSCs have
regional identity and generate distinct neuronal subtypes, or
oligodendrocytes (Merkle et al., 2007; Ventura and Goldman,
2007; Young et al., 2007; Ortega et al., 2013). At present, we
cannot distinguish whether neurons and oligodendrocytes arise
from regionally distinct subpopulations of NSCs in the trans-
planted populations or whether some, or all, NSCs are multipo-
tent in vivo. The extent of in vivo V-SVZ stem cell heterogeneity
and population dynamics of qNSCs and aNSCs, as well as their
lineage relationships and potential under homeostasis and dur-
ing regeneration, will require the identification of novel markers
allowing the specific targeting of qNSCs and aNSCs. Impor-
tantly, our present strategy allows qNSCs to be isolated
irrespective of their regional origin. Of note, the GFAP::GFP+
CD133- population also contains quiescent stem cells. By
combining different reporter mice, it is emerging that V-SVZ
stem cells are molecularly heterogeneous (Giachino et al.,
2014). The iterative identification of additional markers that
allow subpopulations of NSCs to be isolated and targeted in vivo
is a key future step.
Recent findings suggest that quiescent and activated states
are differentially regulated at multiple levels, including cell-cell
and extracellular matrix interactions, diffusible signals and
distinct transcriptional programs coupling cell cycle regulators,
quiescence, self-renewal, and differentiation (Kazanis et al.,
2010; Young et al., 2011; Le Belle et al., 2011; Alfonso et al.,
2012; Basak et al., 2012; Marque´s-Torrejo´n et al., 2013;
Kokovay et al., 2012; Porlan et al., 2013; Giachino et al.,
2014; Kawaguchi et al., 2013, Lo´pez-Jua´rez et al., 2013;
Martynoga et al., 2013). Our transcriptome data of qNSCs
and aNSCs isolated directly from their in vivo niche provide
a platform to functionally assess the gene regulatory networks
active in each state. Interestingly, our GSEA analysis reveals
that GPCR signaling is specifically enriched in qNSCs. While
GPCRs modulate many different facets of adult neurogenesis
(Doze and Perez, 2012), our findings highlight that they
are also key regulators of qNSCs. Strikingly, both functional
ligands we identify in our GPCR screen, S1P and PGD2, inhibit
the activation of qNSCs, suggesting that stem cell quiescence
is an actively maintained state. Both S1P and PGD2 are present
in the CSF (Sato et al., 2007; Kondabolu et al., 2011), which
is emerging as a reservoir of factors in the embryo and the
adult important for stem cell regulation (Silva-Vargas et al.,
2013). As such, the CSF may be a key niche compartment
mediating quiescence in the adult V-SVZ. Interestingly, PGD2
has been implicated in promoting the quiescent phase of the
hair follicle cycle (Garza et al., 2012), which is consistent with
our transcriptome data suggesting that quiescent and activated
stem cells in different tissues share common molecular
pathways.Neuron 82, 545–559, May 7, 2014 ª2014 Elsevier Inc. 555
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are uncovered, it will be important to investigate how clinical
drugs targeting these pathways impact NSCs in vivo. For
instance, fingolimod, an immunomodulatory drug approved by
the Food and Drug Administration for the treatment of multiple
sclerosis (Kappos et al., 2006), acts on S1P receptors. Recent
studies have shown that fingolimod also acts on multiple CNS
cell types (Groves et al., 2013), including astrocytes. Our identi-
fication of S1P as a regulator of stem cell quiescence suggests
that this drug may have an effect on NSCs in the adult brain.
The ability to purify quiescent NSCs from the adult brain opens
new vistas into elucidating the biology of stem cell quiescence,
enabling studies in their intrinsic and extrinsic molecular regula-
tion and defining their dynamics during development and aging.
V-SVZ GFAP+ stem cells are also present in humans, where they
are largely quiescent (Sanai et al., 2004, 2011; van den Berge
et al., 2010). Understanding the biology of stem cell quiescence
and activation will ultimately lead to insight into how NSCs
contribute to brain pathology and can be harnessed for brain
repair.
EXPERIMENTAL PROCEDURES
Animal Use
Experiments were performed in accordance with Columbia University institu-
tional and national guidelines for animal use. All mice usedwere between 2 and
3 months old.
FACS
The FACS strategy was adapted from Pastrana et al. (2009). Briefly, the V-SVZ
was microdissected from GFAP::GFP mice and dissociated with papain, the
single cell suspension was immunostained, and cell populations were purified
by FACS as described in the detailed protocol in Supplemental Experimental
Procedures.
Immunostaining
Whole mounts were dissected and processed as described elsewhere
(Doetsch et al., 1999b; Tavazoie et al., 2008; Mirzadeh et al., 2010). Briefly,
whole mounts were blocked in 10% serum, incubated with primary antibodies
for 48 hr at 4C, revealed with secondary antibodies, and imaged with a Zeiss
LSM510 or Leica TCS SP5 II confocal microscope. All immunostainings were
performed in triplicate. Immunostaining details for whole mounts and cell
cultures are in the Supplemental Experimental Procedures.
In Vitro Assays
For neurosphere assays, FACS-purified cells were collected in neurosphere
medium without growth factors and plated at clonal density with EGF
(20 ng/ml) or EGF/bFGF (20 ng/ml each). For adherent cultures, purified cells
were collected in neurosphere medium and plated on poly-D-lysine and fibro-
nectin-coated 96-well plates as single cells or at clonal density and cultured
with EGF or EGF/bFGF. Further details are given in the Supplemental Experi-
mental Procedures.
Ara-C Infusion
A micro-osmotic pump (ALZET, 1007D) filled with 2% Ara-C (Sigma) in 0.9%
saline was implanted on to the surface of the brain as described elsewhere
(Doetsch et al., 1999b). After 6 days of Ara-C infusion, mice were sacrificed
either immediately or 12 hr after pump removal.
Electroporation
One microliter of a solution containing 5 mg/ml of the mP2-mCherry plasmid in
0.9% saline was electroporated according to Barnabe´-Heider et al. (2008),
using the following coordinates: anterior-posterior (AP), 0.0; lateral (L), 0.85;556 Neuron 82, 545–559, May 7, 2014 ª2014 Elsevier Inc.ventral (V), 2.5 mm relative to bregma. The mP2-mCherry plasmid was
made by cloning the mouse P2 element of the Prominin1 promoter into the
CherryPicker control vector (Clontech), using the XhoI and AgeI digestion
sites. See the Supplemental Information for details.
Transplants
Three injections of 0.2 ml delivering 1,000–3,000 cells purified from
GFAP::GFP/b-actin-PLAP mice were performed in the SVZ of wild-type recip-
ient mice, using the following coordinates: (1) AP, 0.0; L, 1.4; V, 2.1; (2) AP,
0.5; L, 1.1; V,2.2; (3) AP, 1.0; L, 1.0; V,2.5mm relative to bregma. Recipient
mice were sacrificed 1 week or 1 month after transplantation. Transplanted
cells were revealed by NBT/BCIP staining.
RNA Isolation and Microarray Hybridization
RNA was purified from FACS-sorted populations with the miRNeasy kit
(QIAGEN) from three biological replicates. cDNA was synthesized with the
Nugen Pico amplification kit and hybridized to Affymetrix MOE430.2 chips.
See Supplemental Information for details of the bioinformatic analysis.
qRT-PCR
RNA was purified from FACS-sorted populations with the miRNeasy kit
(QIAGEN) and cDNA generated using WT-Ovation Pico System (NuGEN).
See Supplemental Information for details on primer sequences.
GPCR Compound Screen
Cells were isolated by FACS and plated on poly-D-lysine- and fibronectin-
coated 96-well plates in the presence of EGF. To assay the effect on qNSCs,
compounds were added 1 day after plating, and cells were fixed and immuno-
stained at day 4. To assay the effect on aNSCs, cells were plated with com-
pounds and fixed and immunostained 1 day later. Further details are in the
Supplemental Experimental Procedures.
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